Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Understand which index funds to hold in retirement 2024, with practical tips on allocation, rebalancing, and long-term performance.
24,968 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
The Invesco PDBC ETF jumped higher as crude oil rallied to the 98th percentile of its five-year range, highlighting t...
Geopolitical risk is a powerful driver for defense spending. This guide explains how iran fallout: israel needs could...
A major fund recently trimmed its stake in Viridian Therapeutics, signaling potential rotation rather than a verdict ...
Fintech down this year has pressured growth equities, yet cybersecurity ETFs are delivering relative steadiness as co...
A rising wave of spoof calls impersonating bank staff and law enforcement is draining customer accounts. Authorities ...
A year of unprecedented cyber thefts saw North Korean-linked groups drain more than $2 billion from financial network...
Investors eye the long end of the curve as Kevin Warsh's QT stance shifts income dynamics. Forget utility dividends. ...
Privacy-focused crypto Zcash is quietly advancing features that could challenge Bitcoin and Ethereum. This in-depth g...
SpaceX is advancing toward an IPO in mid-June. This guide breaks down what the S-1 reveals, how to assess risk, and p...
SpaceX going public soon would shake investor interest in the space economy. This guide shows how to position yoursel...
The Defense Department expanded its 1260H roster to label Alibaba and Baidu as aiding the PLA, with BYD also targeted...